CD4 and neoplasm: This approach was used to assess the cells collected from tumor tissues and measure CD4 and Foxp3 expression using flow cytometry, where the aCD20@ExoCTX/siPDK4 group significantly inhibited the activity of Treg cells in tumor tissues compared to other groups (Fig. 9D and Supplementary Fig. 22D).